Imaging studies correlating histopathologic biomarkers such as (but is not limited to) ER status, Ki67, and PEPI score will provide valuable insight into breast tumor biology and ultimately allow for the use of imaging as a non-invasive in vivo assay for ER+ breast cancer characterization. The gene discussed is MKI67; the disease is breast cancer.